Preferred Label : trospium chloride;

MeSH note : structure;

CISMeF synonym : Spasmo-Urgenin; ceris; hoyer brand of trospium chloride; intermuti brand of trospium chloride; madaus brand of trospium chloride; medac brand of trospium chloride; pfleger brand of trospium chloride; spasmex; spasmolyt; trospi; uraton;

MeSH synonym : azoniaspiro compound XVII; azoniaspiro(3 alpha-benziloyloxynortropane-8,1'- pyrrolidine) chloride;

MeSH hyponym : Spasmo-Urgenin TC; Spasmo-lyt; Spasmo-Rhoival TC; Uraplex;

MeSH Related Number : 10405-02-4 (trospium chloride);

Registry Number MeSH : 10405-02-4;

Codes EINECS : 233-875-4;

Is substance : O;

UNII : 1E6682427E;

InChIKey : RVCSYOQWLPPAOA-QKYUOBHYSA-M;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3115181/fr/urivesc
2019
false
false
false
France
treatment outcome
administration, oral
Delayed-Action preparations
trospium chloride
trospium
urological agents
muscarinic antagonists
insurance, health, reimbursement
urinary incontinence
urinary incontinence, urge
urinary bladder, overactive
evaluation of the transparency committee
benzilates
nortropanes

---
https://www.has-sante.fr/portail/jcms/c_2829031/fr/ceris
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
trospium chloride
trospium
benzilates
nortropanes

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=65365616
2015
false
false
false
France
French
summary of product characteristics
package leaflet
trospium chloride
benzilates
nortropanes

---
http://www.has-sante.fr/portail/jcms/c_1018495/ceris
http://www.has-sante.fr/portail/jcms/c_1622360/fr/ceris
http://www.has-sante.fr/portail/jcms/c_1622359/fr/ceris-26062013-avis-ct12717
2013
France
French
parasympatholytics
trospium chloride
administration, oral
nortropanes
trospium
urinary incontinence, urge
urinary frequency
treatment outcome
trospium chloride
parasympatholytics
nortropanes
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
benzilates
benzilates
urinary bladder, overactive

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/ceris_-_ct-8295.pdf
http://www.has-sante.fr/portail/jcms/c_1046404/ceris-chlorure-de-trospium-anticholinergique
2011
France
French
parasympatholytics
trospium chloride
administration, oral
nortropanes
trospium
urinary incontinence
treatment outcome
trospium chloride
nortropanes
parasympatholytics
risk assessment
nortropanes
cholinergic antagonists
cholinergic antagonists
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_663731/ceris
2008
France
French
parasympatholytics
trospium chloride
nortropanes
urinary incontinence
tablets
administration, oral
insurance, health, reimbursement
trospium
nortropanes
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Trosec-Fr.pdf
2006
Canada
French
canada
nortropanes
parasympatholytics
urinary bladder, overactive
trospium chloride
nortropanes
drug evaluation

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00154
2006
false
Canada
French
English
parasympatholytics
parasympatholytics
trospium
urinary incontinence
drug approval
canada
drug evaluation, preclinical
treatment outcome
trospium chloride
trospium chloride
nortropanes
nortropanes
administration, oral
nortropanes
drug information

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.